Hope for Alzheimer's prevention emerges as scientists find existing seizure drug may stop disease progression if taken ...

Lamotrigine is primarily used to treat seizures. According to IQVIA data, the estimated market size for the product is $27 ...

Lupin receives USFDA approval for generic Brivaracetam Oral Solution to treat partial-onset seizures. Launch initiated in the US market.

DelveInsight forecasts a rise in the drug-resistant epilepsy market from 2025 to 2034, driven by higher prevalence, improved diagnosis, treatment advances, aging demographics, increased awareness, and ...

Epilepsy surgery has been shown to be an effective treatment for patients with intractable epilepsy. The only randomized controlled trial conducted in this setting to date found a dramatic advantage ...

The pharma giant has officially secured USFDA approval for its generic version of the seizure medication Brivaracetam.

Lupin receives USFDA approval for generic Brivaracetam Oral Solution to treat seizures, initiating its U.S. market launch.

Starting in North Carolina on Tuesday, older House Democrats face a test of their staying power and the appetite of voters to ...

Drugmaker Lupin on Wednesday said it has initiated launch of Brivaracetam Oral Solution 10 mg/mL in the United States following U.S. Food and Drug Administration (U.S. FDA) approval for its ...

The medication is indicated for the treatment of partial-onset seizures in patients one month of age and older.

Mumbai: Mumbai-based pharmaceutical major Lupin Limited has received approval from the US Food and Drug Administration (USFDA) for its Brivaracetam Oral Solution 10 mg/mL and has launched ...

The ouster of Homeland Security Secretary Kristi Noem appeared to have no immediate impact on her department's partial shutdown.